What is Esperion Therapeutics's debt-to-assets?

Esperion Therapeutics (ESPR) reported debt-to-assets of 0.3× in Q1 2026.

How has Esperion Therapeutics's debt-to-assets changed year-over-year?

Esperion Therapeutics's debt-to-assets decreased by 25.6% year-over-year, from 0.5× to 0.3×.

What is the long-term trend for Esperion Therapeutics's debt-to-assets?

Over 5 years (2020 to 2025), Esperion Therapeutics's debt-to-assets has grown at a 81.0% compound annual growth rate (CAGR), from 0× to 0.3×.

What does debt-to-assets mean?

Total debt divided by total assets at the quarter end. Measures the share of the asset base financed by debt.

Esperion Therapeutics ESPR Debt-to-assets

Debt-to-assets at other companies

AmgenAMGN

0.6×0.0×

Regeneron PharmaceuticalsREGN

0.1×0.0×

NewAmsterdam Pharma CompanyNAMS

0×—

Lexicon PharmaceuticalsLXRX

0.2×-0.1×

Zevra Therapeutics, Inc.ZVRA

0×-0.4×

Eton Pharmaceuticals, Inc.ETON

0.3×0.0×

Other financials

Income statement

See full

Revenue$80.1M+23.2%

Operating income-$6.6M+70.2%

Net income-$25.2M+37.7%

EPS (diluted)-$0.10+52.4%

Balance sheet

See full

Cash & equivalents$156.2M+36.2%

Total debt$155.2M+6.1%

Total equity-$307.9M+27.8%

Total assets$462.5M+42.7%

Cash flow

See full

Operating cash flow-$27.7M-22.5%

CapEx$189.0K—

Free cash flow-$27.9M-23.3%

Valuation

See full

Market cap$811.73M+283%

Enterprise value$810.81M+233%

P/S1.9×+1.1×

Profitability

See full

Operating margin18.1%+12.7pp

Net margin-34.8%+8.0pp

FCF margin-30.7%—

Returns & leverage

See full

Return on equity-260.8%—

Debt / equity0.8×—

Current ratio1.5×+0.4×

Where this comes from

Calculated from Esperion Therapeutics’s reported figures.

total debt/total assets=0.3×

Based on the most recent quarter.

The official record: Esperion Therapeutics’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Esperion Therapeutics's debt-to-assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Esperion Therapeutics's debt-to-assets?: Esperion Therapeutics (ESPR) reported debt-to-assets of 0.3× in Q1 2026.
How has Esperion Therapeutics's debt-to-assets changed year-over-year?: Esperion Therapeutics's debt-to-assets decreased by 25.6% year-over-year, from 0.5× to 0.3×.
What is the long-term trend for Esperion Therapeutics's debt-to-assets?: Over 5 years (2020 to 2025), Esperion Therapeutics's debt-to-assets has grown at a 81.0% compound annual growth rate (CAGR), from 0× to 0.3×.
What does debt-to-assets mean?: Total debt divided by total assets at the quarter end. Measures the share of the asset base financed by debt.